Papillary thyroid cancers often occur as microcarcinoma. Some papillary thyroid
microcarcinoma (PTMC) have been considered to be high aggressive according to …

Abstract Background The BRAF V600E mutation, which accounts for about 60–80%
papillary thyroid carcinoma (PTC), has been identifiedas a prognostic marker for risk …

An association between the BRAFV600E mutation and the clinicopathological progression
of papillary thyroid microcarcinoma (PTMC) has been suggested. We aimed to summarize …

Summary Background The BRAFV600E mutation, the most common genetic alteration
reported in papillary thyroid carcinoma, has been associated with poor prognostic factors …

Abstract BRAF V600E mutation has emerged as a marker of aggressive behavior in
papillary thyroid carcinoma but its significance in microcarcinoma is not entirely clear. One …

The prognostic value of the BRAFV600E mutation, resulting in poor clinical outcomes of
papillary thyroid carcinoma, has been generally confirmed. However, the association of …

Background This study analyzed the utility of BRAF mutation screening of ultrasonography-
guided fine-needle aspiration biopsy (FNAB) specimens for predicting aggressive …

Purpose To evaluate the association of known prognostic factors with the BRAFV600E
mutation and its association with ultrasonographic (US) features in Korean patients with …

Background. Papillary thyroid microcarcinoma (PMC;≤ 1 cm) is thought to take a benign
course during the lifetime. However, recent studies showed high recurrence rates for PMC …

Background Papillary thyroid carcinoma (PTC) is one of the most common endocrine
malignancies. It is estimated that papillary thyroid microcarcinoma (PTMC) accounts for up to …